Literature DB >> 12067617

Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity.

Julie A Johnson1, William E Evans.   

Abstract

There is a rapidly growing body of evidence linking genetic polymorphisms with functional changes in proteins that are responsible for the metabolism and disposition of many medications. Likewise, polymorphisms in genes encoding the targets of medications (e.g. receptors) can alter the pharmacodynamics of the drug response by changing receptor sensitivity. As a result, the inherited basis of drug effects is often polygenic in nature, and thus more challenging to define. However, technological advances, coupled with new insights into the molecular pharmacology of medications and the functional consequences of polymorphisms in the human genome, are providing the tools needed to elucidate genetic determinants of drug response, and translate functional genomics into personalized medicine.

Entities:  

Mesh:

Year:  2002        PMID: 12067617     DOI: 10.1016/s1471-4914(02)02354-7

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  7 in total

Review 1.  Pharmacogenetics of osteoporosis: what is the evidence?

Authors:  Francesca Marini; Maria Luisa Brandi
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

2.  Theoretical basis for the identification of allelic variants that encode drug efficacy and toxicity.

Authors:  Min Lin; Rongling Wu
Journal:  Genetics       Date:  2005-03-31       Impact factor: 4.562

3.  Accurate zygote-specific discrimination of single-nucleotide polymorphisms using microfluidic electrochemical DNA melting curves.

Authors:  Allen H J Yang; Kuangwen Hsieh; Adriana S Patterson; B Scott Ferguson; Michael Eisenstein; Kevin W Plaxco; H Tom Soh
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-12       Impact factor: 15.336

Review 4.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

5.  Tensions and Opportunities in Convergence: Shifting Concepts of Disease in Emerging Molecular Medicine.

Authors:  Marianne Boenink
Journal:  Nanoethics       Date:  2009-11-21       Impact factor: 0.917

6.  Pharmacogenetics of osteoporosis.

Authors:  Francesca Marini; Maria Luisa Brandi
Journal:  F1000 Biol Rep       Date:  2010-08-19

7.  Molecular medicine and concepts of disease: the ethical value of a conceptual analysis of emerging biomedical technologies.

Authors:  Marianne Boenink
Journal:  Med Health Care Philos       Date:  2010-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.